| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |